Skip to main content

Table 1 Demographic and clinical characteristics of hGH recipient at screening/baseline

From: Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone

 

Total (N = 136)

Age (years), mean (SD)

12.3 (2.4)

Gender, n (%male)

91 (66.9%)

Height (inches), mean (SD)

57.5 (5.6)

Weight (pounds), mean (SD)

92.9 (33.5)

Race, n (%)

 

White

115 (84.6%)

Black

14 (10.3%)

Asian

2 (1.5%)

Other

5 (3.7%)

Ethnicity, n (%)

 

Hispanic/Latino

12 (8.8%)

Not Hispanic/Latino

124 (91.2%)

Primary diagnosis, n (%)

 

Dwarfism

1 (0.7%)

Fetal growth retardation

1 (0.7%)

Hypopituitarism

3 (2.2%)

Hypopituitarism fetal

1 (0.7%)

Small for gestational age

28 (20.6%)

Turner's syndrome

10 (7.4%)

Growth retardation

15 (11.0%)

Growth hormone deficiency

72 (52.9%)

Body height below normal

4 (2.9%)

Silver-Russell syndrome

1 (0.7%)

Time since diagnosis (years), mean (SD)

5.6 (4.3)